Related Experiment Video
Updated: May 6, 2026
05:31
Transradial Access Chemoembolization for Hepatocellular Carcinoma Patients
Published on: September 20, 2020
5.5K
Emergent transcutaneous embolization in an advanced carcinosarcoma.
Frank Davis1, Gregory G Schaiberger, Yasser Rodriguez
1Department of Internal Medicine (FD, GGS, YR), University of Michigan, Ann Arbor, Michigan; and University of Miami Miller School of Medicine (AO, GGS), Coral Gables, Florida.
The American Journal of the Medical Sciences
|October 26, 2013
Summary
Transcutaneous arterial embolization (TAE) effectively treated active hemorrhage from a rare retroperitoneal carcinosarcoma in a non-operable patient. This life-saving procedure provided palliative care, allowing the patient to live out his remaining life.
Area of Science:
- Oncology
- Interventional Radiology
Background:
- Active hemorrhage is a critical complication of advanced cancers, often indicating a terminal stage.
- Treatment typically involves palliative care for non-operable patients.
Observation:
- A 60-year-old male presented with abdominal and groin pain due to a large retroperitoneal carcinosarcoma.
- The carcinosarcoma was complicated by active bleeding, and the patient was not a surgical candidate.
Findings:
- Transcutaneous arterial embolization (TAE) was successfully performed to control the acute tumor-related hemorrhage.
- The patient's bleeding was effectively halted by the noninvasive TAE procedure.
Implications:
- TAE offers a safe, life-saving alternative for managing acute bleeding in non-operable tumors.
- This case highlights TAE's utility in rare carcinosarcoma presentations and unusual locations, improving palliative outcomes.
